Correct NIH changed it's focus from Home Run to limited therapy. We know Remdesivir has just 1 of the 3 properties that Brilacidin has.
Tamiflu doesn't knock out the flu it makes it a little easier to recover from. Not a home run.
I think the Good Dr. may have jumped ahead with Remdesivir because it allows people to go home sooner 11 vs 15 days. I am very confident that when Brilacidin crosses the Bridge from Lab to Hospitals Trials we will be getting the ultimate recognition as the Home Run or solid Triple.
Fox Business has given it some airtime (wasn't much just a mention of the list but so it begins) only a matter of time before more in-depth coverage comes out in MSM.
Market Data 
Markets 
AI
